Please provide your email address to receive an email when new articles are posted on . In statin-intolerant patients, inflammation risk contributed more to death and CV events than cholesterol risk.
New evidence released today from a study of 31,245 patients already taking statin therapy indicates that inflammation may be a more powerful predictor of risk of future cardiovascular events - such as ...
Please provide your email address to receive an email when new articles are posted on . In patients at high cardiovascular risk already taking statin therapy, level of inflammation better predicted ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window TTHealthWatch is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results